News
Heuking Kühn Lüer Wojtek advises sole shareholder of ...
www.heuking.de
Dr. Heinz-Herbert Fiebig, sole shareholder of Oncotest, on the sale of his shares to Charles River Laboratories International. The transaction total is EUR › article
Panel of melanoma mutations opens door to new treatment possibilities
medicalxpress.com
— Heinz-Herbert Fiebig, M.D., Ph.D., associate professor of medical oncology at the University of Freiburg in Germany, presented data from › news
Ann Arbor's Molecular Imaging Partners With German Biotech ...
www.cbsnews.com
— Oncotest was founded in by Heinz-Herbert Fiebig, M.D., from his pioneering work in predicting the response of a patient towards cancer ... › news
Heuking Kühn Lüer Wojtek berät Alleingesellschafter der ...
www.rws-verlag.de
— Dr. Heinz-Herbert Fiebig, Alleingesellschafter der Oncotest GmbH, bei dem Verkauf seiner Anteile an die Charles River Laboratories ... › newsticker-kanzleien › heu...
sortiert nach Relevanz / Datum